Ethnic and Molecular Disparities in Prostate Adenocarcinoma Incidence: Data from 19 Cohort Studies

This presentation from the CGC 2024 Annual Meeting examines ethnic and molecular disparities in prostate adenocarcinoma incidence using data collected from 19 cohort studies. Delivered by Amy Brady in just 13 minutes, learn about the significant variations in prostate cancer rates across different ethnic groups and the underlying molecular factors that may contribute to these disparities. Gain insights into how these findings might impact diagnosis, treatment approaches, and patient outcomes. The Cancer Genomics Consortium (CGC) continues its mission of promoting best practices in clinical cancer genomics with this informative talk, supporting their vision that all cancer patients receive accurate genomic diagnoses to guide appropriate therapy selection.